Akanda Corp. Announces Termination of Loan Agreement
2023年5月30日 - 5:05AM
ビジネスワイヤ(英語)
International Medical Cannabis Company, Akanda Corp.
(“Akanda” or the “Company”) (NASDAQ: AKAN, WKN: A3DG83)
announces that Akanda and Veridia Canada Ltd. (the “Lender”)
have mutually agreed to terminate the loan agreement between the
parties previously announced on April 18, 2023 (the “Loan
Agreement”). Akanda has returned all funds provided under the
terms of the Loan Agreement and has no further obligations owing to
the Lender pursuant to the Loan Agreement.
About Akanda Corp.
Akanda is an international medical cannabis and wellness
platform company seeking to help people lead better lives through
improved access to high quality and affordable products. Akanda’s
portfolio includes Holigen, a Portugal-based cultivator,
manufacturer and distributor with a prized EU GMP certified indoor
grow facility; CanMart, a UK-based fully licensed pharmaceutical
importer and distributor which supplies pharmacies and clinics
within the UK; and Bophelo Bioscience & Wellness, a GACP
qualified cultivation campus in the Kingdom of Lesotho in Southern
Africa. The Company’s seed-to-patient supply chain also includes
partnerships with California-based Cookies, a leading globally
recognized cannabis company; Cansativa Group, a leading importer
and distributor of medical cannabis in Europe; and Cellen Life
Sciences’ Leva Clinic, one of the first fully digital pain clinics
in the UK.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20230529005134/en/
Investor Contact ir@akandacorp.com
Media Contact Imogen Saunders Irvine Partners
imogen@irvinepartners.co.uk
Akanda (NASDAQ:AKAN)
過去 株価チャート
から 4 2024 まで 5 2024
Akanda (NASDAQ:AKAN)
過去 株価チャート
から 5 2023 まで 5 2024